Meta- and cost-effectiveness analysis of commercial weight loss strategies-Reference-Cited by-同舟云学术

Meta- and cost-effectiveness analysis of commercial weight loss strategies

Published:2014-06-24 Issue:9 Volume:22 Page:1942-1951
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Finkelstein Eric A.¹²,Kruger Eliza¹

Affiliation:

1. Duke-NUS Graduate Medical School; Health Systems and Services Research, Singapore Singapore

2. Duke University, Global Health Institute; Durham North Carolina USA

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/oby.20824/fullpdf

Reference80 articles.

1. Systematic review: an evaluation of major commercial weight loss programs in the United States;Tsai;Ann Intern Med,2005

2. Long-term drug treatment for obesity: a systematic and clinical review;Yanovski;JAMA,2013

3. Recommendations for reporting cost-effectiveness analyses;Siegel;JAMA,1996

4. Medi-Span. Price RX Database 2013

5. Medicare. Fee Schedule, Payment and Reimbursement Benefit Guideline, CPT Code Billing. Office visit CPT, E&M code fee schedule - Florida Medicare 2013 http://www.medicarepaymentandreimbursement.com/2013/01/office-visit-cpt-e-code-fee-schedule.html

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of a Community-Based Telewellness Weight Loss Program;AJPM Focus;2024-04

2. Economic Evaluations of Anti-obesity Interventions in Obese Adults: An Umbrella Review;Obesity Surgery;2024-03-04

3. Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature;Frontiers in Endocrinology;2023-11-06

4. Cost-effectiveness of goal-directed and outcome-based financial incentives for weight loss in low-income populations: the FIReWoRk randomized clinical trial;International Journal of Obesity;2023-11-03

5. Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective;Nutrition, Metabolism and Cardiovascular Diseases;2023-06